COMMON STI571: A BUDGET-FRIENDLY OPTION?

The emergence of off-brand imatinib represents a substantial opportunity for patients battling CML and other diseases. Original brand-name imatinib, branded as Gleevec, carries a high price tag, frequently presenting a challenge for accessibility for some individuals. Off-brand versions, usually